Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: Czechia Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20103
20112
20121
20132
20142
20151
20163
20176
20186
20193
20204
20213
20222
20231
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting9
Terminated9
Active, not recruiting6
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
European Organisation for Research and Treatment of Cancer - EORTC4
Novartis Pharmaceuticals4
Daiichi Sankyo3
Astex Pharmaceuticals, Inc.2
Celgene2
Institute of Hematology and Blood Transfusion, Czech Republic2
Pfizer2
AGC Biologics S.p.A.1
Akinion Pharmaceuticals AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute51
Myelodysplastic Syndromes13
Leukemia12
Recurrence7
Leukemia, Myelomonocytic, Chronic6
Multiple Myeloma5
Lymphoma, Large B-Cell, Diffuse4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Hodgkin Disease3

Trials

Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.